4DX · ASX

4DMedical Ltd (ASX:4DX)

AU$0.55

 0.065 (13.542%)
ASX:Live
04/12/2024 04:10:00 PM
Volume Spike HALO Ords HALO Earnings Momentum GROWTH AUS Big Candle +2
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

4DX Overview

4DX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About 4DX

Telephone

Address

Description

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. It develops pipeline products that may assist physicians to more effectively diagnose and manage patients with lung disease, which includes XV ventilation analysis, ventilation perfusion, contrast free pulmonary angiography, small animal ventilator, and preclinical scanner. The company was founded by Andreas Fouras in December 2012 and is headquartered in Carlton, Australia.

4DX Price Chart

Key Stats

Market Cap

AU$195.34M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.41 - 0.99

Trade Value (12mth)

AU$106,592.00

1 week

6.67%

1 month

-11.11%

YTD

-32.87%

1 year

-48.66%

All time high

2.98

Key Fundamentals

EPS 3 yr Growth

18.60%

EBITDA Margin

%

Operating Cashflow

-$31m

Free Cash Flow Return

-40.90%

ROIC

-47.70%

Interest Coverage

-167.30

Quick Ratio

1.70

Other Data

Shares on Issue (Fully Dilluted)

410m

HALO Sector

Next Company Report Date

28-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.08

4DX Announcements

Latest Announcements

Date Announcements

04 December 24

4DMedical unveils CT VQ at RSNA 2024

×

4DMedical unveils CT VQ at RSNA 2024

02 December 24

4DMedical signs contract to expand in Western Australia

×

4DMedical signs contract to expand in Western Australia

29 November 24

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

25 November 24

4DMedical wins commercial contract with IPOC

×

4DMedical wins commercial contract with IPOC

22 November 24

Notification regarding unquoted securities - 4DX

×

Notification regarding unquoted securities - 4DX

22 November 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

22 November 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

22 November 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

22 November 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

22 November 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

22 November 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

20 November 24

AGM Presentation and Chair's address

×

AGM Presentation and Chair's address

20 November 24

Results of AGM

×

Results of AGM

19 November 24

4DMedical wins 3 year commercial contract with UCSD Health

×

4DMedical wins 3 year commercial contract with UCSD Health

15 November 24

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

08 November 24

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

01 November 24

Notification regarding unquoted securities - 4DX

×

Notification regarding unquoted securities - 4DX

31 October 24

Quarterly Activity Report and Appendix 4C for Q1 FY2025

×

Quarterly Activity Report and Appendix 4C for Q1 FY2025

23 October 24

4DMedical wins $1.9m funding for CT VQ clinical studies

×

4DMedical wins $1.9m funding for CT VQ clinical studies

18 October 24

Notice of Annual General Meeting / Proxy Form

×

Notice of Annual General Meeting / Proxy Form

11 October 24

Notification regarding unquoted securities - 4DX

×

Notification regarding unquoted securities - 4DX

01 October 24

Investor Presentation - Philips update

×

Investor Presentation - Philips update

30 September 24

Annual Report

×

Annual Report

30 September 24

Corporate Governance Statement

×

Corporate Governance Statement

30 September 24

Appendix 4G

×

Appendix 4G

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.08%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

0.10%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

4DX Shortsell

Frequently Asked Questions

The current share price of 4DMedical Ltd (4DX:ASX) is AU$0.55.
The 52-week high share price for 4DMedical Ltd (4DX:ASX) is AU$0.99.
The 52-week low share price for 4DMedical Ltd (4DX:ASX)? is AU$0.41.
4DMedical Ltd (4DX:ASX) does not pay a dividend.
4DMedical Ltd (4DX:ASX) does not pay a dividend.
4DMedical Ltd (4DX:ASX) has a franking level of 0.0%.
4DMedical Ltd (4DX:ASX) is classified in the Technology.
The current P/E ratio for 4DMedical Ltd (4DX:ASX) is .